Comparison of Treatment with Insulin Degludec and Glargine U100 in Patients with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycaemia (HypoDeg): A Prospective, Randomized, Open-Label, Crossover Trial

2020 ◽  
Author(s):  
Rikke Agesen ◽  
Amra Ciric Alibegovic ◽  
Henrik Ullits Andersen ◽  
Henning Beck-Nielsen ◽  
Peter Gustenhoff ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Crossover Trial ◽  
Severe Hypoglycaemia ◽  
Insulin Degludec ◽  
Open Label

scholarly journals Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomised, controlled, open‐label, cross‐over trial

2021 ◽  
Author(s):  
Ulrik Pedersen‐Bjergaard ◽  
Rikke M. Agesen ◽  
Julie M. B. Brøsen ◽  
Amra C. Alibegovic ◽  
Henrik U. Andersen ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Severe Hypoglycaemia ◽  
Insulin Degludec ◽  
Open Label ◽  
Randomised Controlled

Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial

2014 ◽  
Vol 2 (7) ◽  
pp. 553-561 ◽  
Author(s):  
Ulrik Pedersen-Bjergaard ◽  
Peter Lommer Kristensen ◽  
Henning Beck-Nielsen ◽  
Kirsten Nørgaard ◽  
Hans Perrild ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Crossover Trial ◽  
Severe Hypoglycaemia ◽  
Insulin Analogues ◽  
Open Label

scholarly journals Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial

2018 ◽  
Vol 21 (2) ◽  
pp. 349-356 ◽  
Author(s):  
Othmar Moser ◽  
Max L. Eckstein ◽  
Alexander Mueller ◽  
Philipp Birnbaumer ◽  
Felix Aberer ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Crossover Trial ◽  
Insulin Degludec ◽  
Randomized Crossover Trial

Short-term effects of a low carbohydrate diet on glycaemic variables and cardiovascular risk markers in patients with type 1 diabetes: A randomized open-label crossover trial

2017 ◽  
Vol 19 (10) ◽  
pp. 1479-1484 ◽  
Author(s):  
Ajenthen Ranjan ◽  
Signe Schmidt ◽  
Camilla Damm-Frydenberg ◽  
Jens Juul Holst ◽  
Sten Madsbad ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Cardiovascular Risk ◽  
Crossover Trial ◽  
Risk Markers ◽  
Short Term ◽  
Open Label ◽  
Carbohydrate Diet ◽  
Low Carbohydrate Diet ◽  
Low Carbohydrate

scholarly journals The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design

2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Rikke Mette Agesen ◽  
Amra Ciric Alibegovic ◽  
Henrik Ullits Andersen ◽  
Henning Beck-Nielsen ◽  
Peter Gustenhoff ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
High Risk ◽  
Severe Hypoglycaemia ◽  
Insulin Degludec ◽  
Nocturnal Hypoglycaemia

scholarly journals Fast-Acting Insulin Aspart Versus Insulin Aspart Using a Second-Generation Hybrid Closed-Loop System in Adults With Type 1 Diabetes: A Randomized, Open-Label, Crossover Trial

Diabetes Care ◽  
2021 ◽  
pp. dc210814
Author(s):  
Melissa H. Lee ◽  
Barbora Paldus ◽  
Sara Vogrin ◽  
Dale Morrison ◽  
Dessi P. Zaharieva ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Insulin Aspart ◽  
Closed Loop ◽  
Crossover Trial ◽  
Closed Loop System ◽  
Open Label ◽  
Acting Insulin ◽  
Fast Acting ◽  
Generation Hybrid
Sign in / Sign up

Export Citation Format

Share Document